Another quarterly earnings announcement from Novo Nordisk and another downgrade to earnings guidance from the Danish ...
Investor's Business Daily on MSN
Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates
Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 ...
Novo Nordisk is raising the stakes in its push to outbid rival Pfizer and acquire the development-stage drugmaker Metsera. Novo is now offering to pay as much as $10 billion for the company, Metsera ...
Axios Visuals Pfizer and Novo Nordisk on Tuesday both sweetened their bids for weight-loss drugmaker Metsera, to a maximum of $8.1 billion and $10 billion, respectively. Why it matters: This reflects ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title, registration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback